Eisenreich A - Search Results

1

Tissue factor expression pattern in human non-small cell lung cancer tissues indicate increased blood thrombogenicity and tumor metastasis.

Goldin-Lang P, Tran QV, Fichtner I, Eisenreich A, Antoniak S, Schulze K, Coupland SE, Poller W, Schultheiss HP, Rauch U. Goldin-Lang P, et al. Among authors: eisenreich a. Oncol Rep. 2008 Jul;20(1):123-8. Oncol Rep. 2008. PMID: 18575726

2

Upregulation of tissue factor expression and thrombogenic activity in human aortic smooth muscle cells by irradiation, rapamycin and paclitaxel.

Eisenreich A, Celebi O, Goldin-Lang P, Schultheiss HP, Rauch U. Eisenreich A, et al. Int Immunopharmacol. 2008 Feb;8(2):307-11. doi: 10.1016/j.intimp.2007.06.005. Epub 2007 Jul 2. Int Immunopharmacol. 2008. PMID: 18182245

3

Cdc2-like kinases and DNA topoisomerase I regulate alternative splicing of tissue factor in human endothelial cells.

Eisenreich A, Bogdanov VY, Zakrzewicz A, Pries A, Antoniak S, Poller W, Schultheiss HP, Rauch U. Eisenreich A, et al. Circ Res. 2009 Mar 13;104(5):589-99. doi: 10.1161/CIRCRESAHA.108.183905. Epub 2009 Jan 22. Circ Res. 2009. PMID: 19168442

4

Prolonged clopidogrel application reduces tissue factor expression after percutaneous coronary intervention in the porcine model.

Ayral Y, Rauch U, Goldin-Lang P, Eisenreich A, Pepke W, Deiner C, Schwimmbeck PL, Schultheiss HP, Pels K. Ayral Y, et al. Among authors: eisenreich a. Cardiovasc Revasc Med. 2011 Jan-Feb;12(1):47-55. doi: 10.1016/j.carrev.2009.12.001. Epub 2010 Oct 20. Cardiovasc Revasc Med. 2011. PMID: 21241972

5

Regulation of pro-angiogenic tissue factor expression in hypoxia-induced human lung cancer cells.

Eisenreich A, Zakrzewicz A, Huber K, Thierbach H, Pepke W, Goldin-Lang P, Schultheiss HP, Pries A, Rauch U. Eisenreich A, et al. Oncol Rep. 2013 Jul;30(1):462-70. doi: 10.3892/or.2013.2413. Epub 2013 Apr 22. Oncol Rep. 2013. PMID: 23604472

6

Regulation of cardiomyocyte full-length tissue factor expression and microparticle release under inflammatory conditions in vitro.

Antoniak S, Boltzen U, Eisenreich A, Stellbaum C, Poller W, Schultheiss HP, Rauch U. Antoniak S, et al. Among authors: eisenreich a. J Thromb Haemost. 2009 May;7(5):871-8. doi: 10.1111/j.1538-7836.2009.03323.x. Epub 2009 Feb 18. J Thromb Haemost. 2009. PMID: 19228282 Free article.

7

Alternatively spliced tissue factor and full-length tissue factor protect cardiomyocytes against TNF-α-induced apoptosis.

Boltzen U, Eisenreich A, Antoniak S, Weithaeuser A, Fechner H, Poller W, Schultheiss HP, Mackman N, Rauch U. Boltzen U, et al. Among authors: eisenreich a. J Mol Cell Cardiol. 2012 May;52(5):1056-65. doi: 10.1016/j.yjmcc.2012.01.015. Epub 2012 Jan 31. J Mol Cell Cardiol. 2012. PMID: 22326437 Free PMC article.

8

Effects of the Cdc2-like kinase-family and DNA topoisomerase I on the alternative splicing of eNOS in TNF-alpha-stimulated human endothelial cells.

Eisenreich A, Boltzen U, Poller W, Schultheiss HP, Rauch U. Eisenreich A, et al. Biol Chem. 2008 Oct;389(10):1333-8. doi: 10.1515/BC.2008.152. Biol Chem. 2008. PMID: 18713021

9

Role of the phosphatidylinositol 3-kinase/protein kinase B pathway in regulating alternative splicing of tissue factor mRNA in human endothelial cells.

Eisenreich A, Malz R, Pepke W, Ayral Y, Poller W, Schultheiss HP, Rauch U. Eisenreich A, et al. Circ J. 2009 Sep;73(9):1746-52. doi: 10.1253/circj.cj-99-0225. Epub 2009 Jul 13. Circ J. 2009. PMID: 19597299 Free article.

10

PI3K inhibitors in cardiovascular disease.

Eisenreich A, Rauch U. Eisenreich A, et al. Cardiovasc Ther. 2011 Feb;29(1):29-36. doi: 10.1111/j.1755-5922.2010.00206.x. Cardiovasc Ther. 2011. PMID: 20626398 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters